|   |   | 
Legal status
Patent not validated
| (51) | INT.CL. | C07D 411/04 | 
| (11) | Number of the document | 2542551 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 11713057.5 | 
| Date of filing the European patent application | 2011-02-25 | |
| (97) | Date of publication of the European application | 2013-01-09 | 
| (45) | Date of publication and mention of the grant of the patent | 2014-08-27 | 
| (46) | Date of publication of the claims translation | 
| (86) | Number | PCT/IB2011/050824 | 
| Date | 2011-02-25 | 
| (87) | Number | WO 2011/107920 | 
| Date | 2011-09-09 | 
| (30) | Number | Date | Country code | 
| DE04892010 | 2010-03-04 | IN | 
| (72) | 
                    
                    
                    
                    
                    KSHIRSAGAR, Prakash Bhimaji, IN  
                    
                    
                    
                    
                    BHOGE, Satish Manohar, IN  
                    
                    
                    
                    
                    RICHHARIYA, Santosh, IN  
                    
                    
                    
                    
                    SINGH, Kaptan, IN  | 
| (73) | Ranbaxy Laboratories Limited,
                Head Office: 12th Floor  Devika Tower  06 Nehru Place  New Delhi, Delhi 110019,
                IN | 
| (54) | A PROCESS FOR STEREOSELECTIVE SYNTHESIS OF 5-FLUORO-1-(2R,5S)-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE | 
| A PROCESS FOR STEREOSELECTIVE SYNTHESIS OF 5-FLUORO-1-(2R,5S)-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE |